Company Performance Metrics
Bioflares develops bioluminescent imaging technologies and reagents for in vivo biological research. The company focuses on a chemical-biological platform built around infraluciferin substrates and engineered infraluciferase (iLuc) enzymes that emit in the far-red to near-infrared range for deep tissue imaging. Its technology supports
dual-parameter bioluminescence, enabling simultaneous tracking of multiple cell types, genes, or biological processes in a single subject. Bioflares supplies products such as D-infraluciferin methyl ester for in vivo imaging and pCCL-based luciferase vectors for cell engineering and assay development. These tools are used in applications including CAR T-cell therapy studies, vaccine research, and other preclinical models that require longitudinal, non-invasive imaging. The company also offers codon-optimized DNA constructs and related technical resources to support laboratory adoption of its imaging platform.